Plasmanate Solution
Product Images NDC 13533-613

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Plasmanate (NDC 13533-613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Grifols Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton

Carton
This product is a plasma protein fraction used for intravenous infusion only, containing sodium, potassium, and chlorides. It is important to discuss the risks and benefits of this product with a physician before using it. The enclosed package insert should be read carefully for dosage and administration instructions. The product must be stored at room temperature and should not be frozen. It is not returnable for credit or exchange. The product should not be used if the shrink band is absent or shows any sign of tampering, and the manufacturer should be notified immediately. If the container has been entered, administration should not begin after 4 hours.*
FDA Label Image

Label

Label
This appears to be a product label for Plasmanate, a plasma/prot (human) solution for intravenous infusion. It is heated at 60 degrees Celsius for 10 hours and comes in a 250 mL container. The label provides information on storage, dosage and administration, and ingredients. The solution is manufactured by Grifolg Theraputics LLC in Research Triangle Park, NC, USA. There is some unclear text such as "DG s sH3zE" and "Sotium Potassum. Chiorde." which may be caused by error.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.